Retroperitoneoscopic Donor Nephrectomy
Launched by SAMSUN LIV HOSPITAL · Mar 26, 2019
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
This was a retrospective study evaluating demographics, intraoperative and postoperative data of 158 kidney donors who underwent RDN from January 2010 to August 2018. Two groups were created according to the side of the surgery including Right RDN (group 1) and left RDN (group 2). The results of the recipients' were also evaluated.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult donors
- • Kidney donors undergoing retroperitoneoscopic donor nephrectomy
- • Recipients of the kidneys
- • Donors with the consent form
- • Recipients with consent form
- Exclusion Criteria:
- • open donor nephrectomies
- • donors without the consent form
- • Recipients without the consent form
About Samsun Liv Hospital
Samsun Liv Hospital is a leading healthcare institution dedicated to advancing medical research and patient care through innovative clinical trials. Located in Samsun, Turkey, the hospital is equipped with state-of-the-art facilities and a multidisciplinary team of experienced professionals committed to delivering high-quality healthcare services. With a focus on patient safety and ethical standards, Samsun Liv Hospital actively collaborates with researchers and industry partners to explore new therapeutic approaches and improve health outcomes across various medical fields. Through its robust clinical trial program, the hospital aims to contribute to the global body of medical knowledge while enhancing the quality of life for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Samsun, , Turkey
Samsun, , Turkey
Patients applied
Trial Officials
Saban Sarıkaya, Professor
Study Chair
Ondokuz Mayıs University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials